ArticleWorld journal of microbiology & biotechnology2026
Clinical features and factors associated with severe illness in pediatric acute respiratory tract infections due to Escherichia coli: a retrospective tNGS-based study.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To investigate the detection rate, clinical characteristics, and factors associated with intensive care unit (ICU) admission in hospitalized children with acute respiratory tract infection (ARTI) involving Escherichia coli (E. coli). Bronchoalveolar lavage fluid samples from 4,199 hospitalized children were tested using targeted next-generation sequencing (tNGS). Clinical characteristics, laboratory parameters, imaging findings, and outcomes of E. coli-positive children were analyzed, with comparisons between ICU and non-ICU groups. E. coli was detected in 107 cases (2.5%). The median age was 7 months; males accounted for 70.1%, and 29.0% had underlying diseases. Mixed infections occurred in 95.3% of cases, with cytomegalovirus (47.7%), Pneumocystis jirovecii (38.3%), Mycoplasma pneumoniae (28.0%), and rhinovirus (27.1%) being the most common co-pathogens. Chest CT findings mainly showed increased bronchovascular markings (78.2%) and patchy opacities (72.3%). Respiratory support was required in 43.9% of cases, and 18.7% were admitted to the ICU. The median hospital stay was 9 days, and 95.3% were discharged after recovery. Compared with the non-ICU group, the ICU group had higher proportions of children aged ≤ 1 month (25.0% vs. 8.0%), underlying diseases (50.0% vs. 24.1%), fever, tachypnea, and dyspnea, as well as elevated procalcitonin and D-dimer levels (all P < 0.05). The detection rate of E. coli in hospitalized children with ARTI was 2.5%, predominantly affecting young infants and frequently involving underlying comorbidities (29.0%). Mixed infections are common, and 18.7% of patients require admission to the ICU. Young age, underlying diseases, fever, tachypnea, and elevated procalcitonin and D-dimer levels were clinical features significantly associated with ICU admission in affected children.
Indexed as
Identifiers
42837049What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.